The latest news, trends, analysis, interviews and podcasts from the global food and beverage industry
IMCD Group has officially opened a new Technical Centre in Istanbul, expanding its regional innovation and formulation capabilities across food and nutrition, pharmaceuticals, beauty and personal care and coatings and construction.
Located in the Ataşehir district of Istanbul, the new facility consolidates several previously separate laboratories into a single integrated hub designed to provide formulation development, technical consultancy, pilot testing and product optimisation support for customers across Türkiye and neighbouring regions.
The investment forms part of IMCD’s wider global network of more than 80 technical centres and laboratories and reflects growing demand for localised innovation support within the speciality ingredients and chemicals sectors.
For the food and beverage industry, the new IMCD Türkiye Food & Nutrition Applications Laboratory will focus on supporting manufacturers in dairy, bakery, beverages, confectionery, meat and savoury categories. The laboratory combines global consumer trend insights with technical expertise to help brands optimise taste, texture, functionality and nutritional value in new product development.
The facility also offers pilot trials, ingredient optimisation and ready-to-use prototype concepts intended to accelerate speed-to-market for food and beverage manufacturers.
Aylin Zakuto, managing director of IMCD Türkiye, said: "Our Centre will be a chemical technology hub where customers will be able to accelerate product selection and formulation and attend technical training and seminars, leveraging IMCD’s global and local expertise to seize every local market opportunity."
The centre additionally introduces a dedicated pharmaceuticals laboratory for the first time in Türkiye, serving not only the domestic market but also the Middle East, Maghreb region, Egypt, Kenya and South Africa.
The pharmaceutical facility supports development across solid, liquid and semi-solid dosage forms, including active pharmaceutical ingredients and formulation support. According to the company, all development activities follow internationally recognised risk-based methodologies and Quality by Design principles to ensure robustness and reproducibility.
There are also purpose-built facilities for skincare, haircare, sunscreen and hygiene formulations and development and testing for decorative and industrial paints, wood coatings, adhesives and thermal insulation systems.
Headquartered in Rotterdam, IMCD Group operates across more than 60 countries and serves sectors including food and nutrition, pharmaceuticals, advanced materials and industrial solutions.
The company reported revenues of €4.779 billion in 2025 and employs more than 5,200 people globally. IMCD shares are traded on Euronext Amsterdam under the ticker IMCD.